MedTrace Logo

PROMOTE: A Pilot and Feasibility Study

NCT07758439 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2026-08-11

No results posted yet for this study

Summary

To assess the feasibility and acceptability of implementing and evaluating shared decision making (SDM) within a single opioid treatment program (OTP) using Implementation Facilitation (IF), and to obtain pilot data on key implementation and effectiveness outcomes to inform a future full-scale hybrid type 3 implementation-effectiveness trial.

Conditions

  • Shared Decision Making

Interventions

BEHAVIORAL

Implementation facilitation for shared decision making

Implementation Facilitation (IF) is a systematic approach to integrating implementation activities to support and enable individual and organizational adoption of innovations. IF will be tailored to support shared decision making in a single opioid treatment program (OTP) and will be implemented over a 6-month period to assess feasibility of this implementation intervention in an OPT setting.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Yale University

    collaborator OTHER

  • New York University

    collaborator OTHER

  • Berkshire Medical Center

    collaborator OTHER

  • Community Medical Services, LLC

    collaborator UNKNOWN

  • Penn State College of Medicine

    collaborator UNKNOWN

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Paul Joudrey, MD, MPH · University of Pittsburgh

  • Cristina Murray-Krezan, PhD · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-05-31
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07758439 on ClinicalTrials.gov